PURPOSE: To evaluate the usefulness of transcatheter @entity1416 (TAE) through the omental branch in the treatment of @entity157 ( @entity157 ) with blood supply from the omental branch. MATERIALS AND METHODS: Fifteen @entity1 with @entity157 fed by the omental branch underwent TAE. All but one had previously undergone several therapies for @entity157 , including TAE. Three @entity1 had intraperitoneal @entity548 caused by @entity157 fed by the omental branch, and two necessitated emergency TAE. The technical success rate, therapeutic effect, and safety of TAE via the omental branch were evaluated. RESULTS: Twenty-six omental branches that fed @entity157 were observed angiographically. Attenuation or occlusion of the hepatic artery was observed in 80%. @entity3314 (73%) could be successfully embolized. Hepatic hemostasis was achieved in all @entity1 with @entity157 . @entity5 recurred in 80% of @entity1 who underwent successful TAE of the omental branch, and additional therapy was performed in six @entity1 . Ten @entity1 died after 2-26 months (mean, 8 mo). Five @entity1 were alive for 3-13 months (mean, 7 mo). Severe complications were not observed in any @entity1 . CONCLUSION: TAE of the omental branch is safe and has become technically feasible in almost all @entity1 , but @entity5 frequently recur.

XXXX with blood supply from omental branches: treatment with transcatheter @entity1416 .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity548 :: ('MESH:D006470', 'Disease') :: ['hemorrhage'] @entity5 :: ('MESH:D009369', 'Disease') :: ['Tumor', 'tumors'] @entity1416 :: ('MESH:D020762', 'Disease') :: ['arterial embolization'] @entity3314 :: ('MESH:D015436', 'Disease') :: ['Nineteen omental branches'] @entity157 :: ('MESH:D006528', 'Disease') :: ['HCC', 'ruptured HCC', 'hepatocellular carcinoma']
@entity157 :: (MESH:D006528,Disease) :: ['Hepatocellular carcinoma']
